BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36890005)

  • 1. Survival Nomogram for Patients With Locally Advanced Breast Cancer Undergoing Immediate Breast Reconstruction: A SEER Population-Based Study.
    Pan J; Peng L; Xia C; Wang A; Tong X; Chen X; Zhang J; Xu X
    Clin Breast Cancer; 2023 Jun; 23(4):e219-e229. PubMed ID: 36890005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Zhao J; Bian S; Di X; Xiao C
    Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional survival nomogram predicting real-time prognosis of locally advanced breast cancer: Analysis of population-based cohort with external validation.
    Meng X; Hao F; Ju Z; Chang X; Guo Y
    Front Public Health; 2022; 10():953992. PubMed ID: 36388300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
    Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
    BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.
    Meng X; Chang X; Wang X; Guo Y
    Clin Breast Cancer; 2022 Oct; 22(7):681-689. PubMed ID: 35853792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study.
    Wu J; Xie Z; Xiao Y; Wang B; Zhang P
    Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.
    Diao JD; Ma LX; Sun MY; Wu CJ; Wang LJ; Liu YL; Yang YJ
    Cancer Med; 2019 Sep; 8(12):5600-5608. PubMed ID: 31407527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
    Jiao S; Guo L; Da F; Gao Q; Ren Z; Wang J; Fu Q; Liu J
    Technol Cancer Res Treat; 2023; 22():15330338231164191. PubMed ID: 37078156
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
    Liang M; Chen M; Singh S; Singh S
    Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms for Predicting Cancer-Specific Survival of Patients with Gingiva Squamous Cell Carcinoma: A Population-Based Study.
    Yang SS; Zhong XH; Wang HX; Min AJ; Wang WM
    Curr Med Sci; 2021 Oct; 41(5):953-960. PubMed ID: 34693495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
    Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
    Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
    Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
    BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
    Huang Q; Xu TY; Wu ZY
    Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysis.
    Wang M; Chen H; Wu K; Ding A; Zhang P; Zhang M
    Breast Cancer Res Treat; 2019 Jul; 176(2):337-347. PubMed ID: 31020469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.